Apolipoprotein E*Ɛ2 carriers exhibit high aspirin-treated platelet reactivity and low cardiovascular risk during long-term aspirin treatment.
Sign Up to like & getrecommendations! Published in 2022 at "Age and ageing"
DOI: 10.1093/ageing/afac119
Abstract: OBJECTIVE Apolipoprotein E (APOE) loci, including rs429358 (Ɛ4) and rs7412 (Ɛ2), are involved in cardiovascular (CV) health. However, their effect on the CV-protective effect of aspirin remains unknown. METHODS A total of 515 aspirin-treated individuals… read more here.
Keywords: long term; aspirin treated; term aspirin; risk ... See more keywords
Understanding the barriers to using oral anticoagulants among long-term aspirin users with atrial fibrillation – a qualitative study
Sign Up to like & getrecommendations! Published in 2020 at "BMC Health Services Research"
DOI: 10.1186/s12913-020-05947-3
Abstract: Despite international treatment guidelines currently advocating oral anticoagulants (OACs) as the only appropriate stroke prevention therapy for patients with atrial fibrillation (AF) and evidence that OACs can greatly reduce the risk of stroke with similar… read more here.
Keywords: atrial fibrillation; long term; oral anticoagulants; aspirin ... See more keywords